Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Would love to agree withpeoples optimism... looks to me MMs are just playing with the price today in order not to show flat line...
Easy 10 - 12 Pence for starters..then boom
Dallo,
Anything could happen but as you know well, IMM has a history of making lots of promises yet have never delivered on anything , IMO
Great story but rarely a happy ending is my view but one never knows ....
Nolupus
40p probably wishful thinking but increasing interest in peptide drug systems among the Pharma giants may tempt a bid given the patents held by Immupharma in this area plus Lupuzor if FDA approve another Phase 3 trial and the improving outlook for Incanthera's Sol cancer sun cream.
Buying interest building today some maybe news coming.
Imho
Does anyone know whether the 310,000 transaction that went through yesterday at 17.06 was a buy or a sell?
Icarus;
I agree - the current sp represents a realistic risk/reward level for IMM. It is interesting that there is support for the 9p level despite the lack of news from the Board. I guess that many investors like me are banking on a positive response from FDA in this quarter to the PK info from IMM that they requested.
Forgot to add - looking for a cross above 10.6p then 12.6p and then we can say the SP is really bullish. News Tim, that's what we are all anticipating.
I believe a fair valuations is 30p+, however as Nolupus has stated that it is where it is, but that could all change on a single RNS. That could be either on updtate from Ureka, or P3 trials Avion are leading on.
My guess is this presents a good risk/reward at current price.
One should always be aware that this is small pharma the riskiest of the riskiest and no amount of market experience can deflect from that reality.So sizing of position accordingly is paramount.
I have a position here and will add with a break above the 20week MA @ 10.6p.My stop is 6p.
I am bullish,those who are trapped higher should not despair,small pharma shocks on the downside and the upside.
Best of luck.
Icarus42,
The market is the market and the SP is where it’s at because of shareholder lassitude of delays and NO proper communication or trust in management , imo
That could all change with one decent RNS but shareholder patience is well and truly tested
Nolupus,
Do you see this company fairly priced currently ?
Dallo,
A buy out whilst a possibility is imo wishful thinking at this stage ...
IMM needs to advance it’s pipeline and FAST , imo
This radio silence is deafening....
I would want more than 40p and with trials progressing and peptide research being undertaken by Ureka I would say a positive update on that front will get things moving. Expecting this to move up today.....so a case of adding and holding for me.
Cauldstream
40p buyout would seal the deal giving a market cap of £85m and someone else taking the risk of another failed Phase 3 for Lupuzor.
Most investors here would jump at such an offer given the last 3 years of abject management failure.
Dallo.
40p would signal failure. What is the hurry to sell the company? The costs of the Phase 3 trial will be covered by Avion and there are several drugs in the IMM pipeline due to come to market in late 2022 and 2023 with funding assured for a further 2 years.
I doubt if Dr Zimmer would accept such a low price.
A final guidance meeting with the FDA is expected to take place in Quarter 2 ie now until 30 June following further clinical submissions on Lupuzor by Immupharma and Avion.
So news on the Phase 3 approval by the FDA could hit the market at any time over the next 10 weeks.
Approval will send share price higher and set up a sale of Immupharma to a larger player imho.
I think that is what the outcome will be and it is going to be all about price as the company has no resources to go it alone and has disappointed shareholders for too long.
A takeout price of 40p would seal the deal.
If no FDA go ahead then we will be lucky to sell at 8p but I am still optimistic for what is is worth.
Nolupus will no doubt have his views but endgame now in sight after a roller coaster 3 years.
Imho
Dyor
I should say a nice delayed reporting of a big earlier buy that lifted it off the bottom. Bouncy bouncy. No MM got some shares they will take it up now..
Strong buy
Wow: Nice big buy at the end.. So back up we go. Nice bounce coming..
Loads of bigger buys going through......will finish on the high.
Gap appears to have been filled from the rise last week. Now have a look to see if it can move and break above 10.5p